Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

MPI - Interim Report First Half 2016

Medical Prognosis Institute
Posted on: 31 Aug 16
st 2016 - Medical Prognosis Institute A/S (MPI) announces the Company's Interim Report First Half 2016.  

Interim Report First Half 2016

The Board of Directors for Medical Prognosis Institute A/S has today discussed and approved the Interim Report First Half 2016.

Please find the full Interim report on .

For further information, please contact
Peter Buhl Jensen, CEO
Cell Phone: +45 21 60 89 22

This information is information that Medical Prognosis Institute A/S is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on 31st A ugust 2016.

Certified Advisor: Sedermera Fondkommission, Norra Vallgatan 64, 211 22, Malmö, Sweden

MPI - H1 2016
MPI - Publication of H1 2016 Interim Report

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Medical Prognosis Institute via GlobeNewswire

Last updated on: 01/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.